NOTICE OF ALLOWANCE - ISSUED
issued
on 26 Nov 2024
Last Applicant/ Owned by
100 BEAVER STREET, SUITE 307
WALTHAM
MA
02453
Serial Number
97810745 filed on 24th Feb 2023
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
TRIVENI
Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharm Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; scientific research, namely, genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research, namely, DNA analysis and sequencing services for scientific and research purposes; scientific research, development and scientific research consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical, therapeutic and biopharmaceutical agents for treatment of immunological and inflammatory disorders; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for treatment of genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; biological preparations, namely, antibodies for medical purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97810745
Mark Type
No Service/Collective Mark
Attorney Docket Number
No M16022000000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Nov 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 15th Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Oct 2024 | PUBLISHED FOR OPPOSITION |
| 25th Sep 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 03rd Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 03rd Sep 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 03rd Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 08th Jul 2024 | NON-FINAL ACTION E-MAILED |
| 08th Jul 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |